Correlogic Systems (Ovarian Cancer Diagnostics Business) Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Correlogic Systems (Ovarian Cancer Diagnostics Business) General Information

Description

Developer of diagnostic test for ovarian cancer. The business unit's assets include more than 1,000 prospectively collected diagnostic samples from ovarian tumor studies, three biomarker-related pending U.S. patents, proprietary software and other intellectual property.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1405 Research Boulevard
  • Suite 220
  • Rockville, MD 20850
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Correlogic Systems (Ovarian Cancer Diagnostics Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Correlogic Systems (Ovarian Cancer Diagnostics Business)‘s full profile, request access.

Request a free trial

Correlogic Systems (Ovarian Cancer Diagnostics Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Correlogic Systems (Ovarian Cancer Diagnostics Business)‘s full profile, request access.

Request a free trial